Pediatric Surgery International

, Volume 24, Issue 7, pp 809–813 | Cite as

Protective effects of vitamin E and omeprazole on the hypoxia/reoxygenation induced intestinal injury in newborn rats

  • Faysal O. Cadir
  • Unal Bicakci
  • Burak TanderEmail author
  • Birsen Kilicoglu-Aydin
  • Riza Rizalar
  • Ender Ariturk
  • Oguz Aydin
  • Ferit Bernay
Original Article


Evaluation of prophylactic effects of omeprazole and/or vitamin E on the formation of free oxygen radicals (FOR) and bowel histopathology in the newborn rat model of hypoxia/reoxygenation (H/R) that resembles human necrotizing enterocolitis (NEC). Eighty newborn rats were randomly divided into eight groups. H/R was done using airtight chamber. Rats were exposed to 100% CO2 for 15 min followed by a reoxygenation for the next 15 min with 100% O2. Group 1 (n = 10) was the control group. Group 2 (n = 10) rats received vitamin E. In Group 3 (n = 10) omeprazole was administrated. Group 4 (n = 10) rats received omeprazole and vitamin E. Group 5 (n = 10) rats were subjected to H/R two times for 2 days and one time for 3 days. Group 6 (n = 10) received vitamin E in addition to H/R for 5 days and in Group 7 (n = 10) omeprazole in addition to H/R for 5 days. In Group 8 (n = 10), vitamin E and omeprazole and H/R were applied for 5 days. Rats were killed at the end of the each process and bowel specimens were harvested for histopathological and biochemical investigations. We administrated vitamin E intramuscularly 300 unit/kg per day and omeprazole orally 20 mg/kg per day. Malondialdehyde (MDA), xanthine oxidase (XO), xanthine dehydogenase (XDH) and XO/(XO + XDH) were measured. Vitamin E and/or omeprazole treated rats had significantly less XO% levels than H/R only group (0.36, 0.38 and 0.57, respectively). Similarly, the MDA levels were significantly lower in vitamin E and/or omeprazole received rats than H/R only rats (88.8, 97.9 and 122.6, respectively). All rats treated with omeprazole and/or vitamin E had better biochemical and histopathological levels compared to H/R rats (p < 0.05). Histopathological results show that Group 5 (H/R only) had significantly more intestinal damage when compared with Group 6 (vitamin E + H/R), Group 7 (omeprazole + R/H) and Group 8 (vitamin E + omeprazole + H/R) (p < 0.001). Grade 2 and 3 intestinal damages were only in Group 5 and there were no statistical difference between in Groups 6, 7 and 8 (p > 0.001). Omeprazole and/or vitamin E may protect the biochemical and histopathological intestinal damage of H/R injury in rats. These drugs may be beneficial in the prophylaxis of NEC in humans as well.


Necrotizing enterocolitis Intestinal hypoxia-reoxygenation Omeprazole Vitamin E 


  1. 1.
    Huesh W, Caplan MS, Qu XW (2002) Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts. Pediatr Dev Pathol 6:6–23CrossRefGoogle Scholar
  2. 2.
    Kosloske AM, Musemeche CA (1989) Necrotizing enterocolitis of the neonate. Clin Perinatol 16(1):97–111PubMedGoogle Scholar
  3. 3.
    Lawrence G, Bates J, Gaul A (1982) Pathogenesis of neonatal necrotising enterocolitis. Lancet 1(8264):137–139PubMedCrossRefGoogle Scholar
  4. 4.
    Lucas A, Cole TJ (1990) Breast milk and neonatal necrotising enterocolitis. Lancet 336:1519–1523PubMedCrossRefGoogle Scholar
  5. 5.
    Beuk RJ, oude Egbrink MG, Kurvers HA, Bonke HJ, Tangelder GJ, Heineman E (1996) Ischemia/reperfusion injury in rat mesenteric venules: red blood cell velocity and leukocyte rolling. J Pediatr Surg 31(4):512–515Google Scholar
  6. 6.
    Kliegman RM, Walsh MC (1987) Neonatal necrotizing enterocolitis: pathogenesis, classification and spectrum of illness. Curr Probl Pediatr 17(4):213–288PubMedCrossRefGoogle Scholar
  7. 7.
    Caty MG, Schmeling DJ, Friedl HP (1990) Histamine: a promoter of xanthine oxidase activity in intestinal ischemia/reperfusion. J Pediatr Surg 25(2):218–223PubMedCrossRefGoogle Scholar
  8. 8.
    Hirata Y, Ishii K, Taguchi T (1993) Conversion of xanthine dehydrogenase to xanthine oxidase during ischemia of the rat small intestine and the effect of trifluoperazine on the conversion. J Pediatr Surg 28(4):597–600PubMedCrossRefGoogle Scholar
  9. 9.
    Parks DA, Williams TK, Beckman JS (1988) Conversion of xanthine dehyrogenase to oxidase in ischemic rat intestine: a reevaluation. Am J Physiol 254:768–774Google Scholar
  10. 10.
    Buescher ES (1994) Host defence mechanisms of human milk and their relations to enteric infections and necrotizing enterocolitis. Clin Perinatol 21(2):247–262PubMedGoogle Scholar
  11. 11.
    Caplan MS, Hedlund E, Adler L (1994) Role of asphyxia and feding in a neonatal rat model of necrotizing enterocolitis. Pediatr Pathol 14:1017–1028PubMedCrossRefGoogle Scholar
  12. 12.
    Ak H, Dingiloglu NT, Habif S (1996) Plasma lipid peroxides, vitamin E, superoxidase dismutase and glutathione alterations in coronary atherosclerosis. Turk J Med Sci 26:11–15Google Scholar
  13. 13.
    Bicakci U, Tander B, Ariturk E (2005) Effects of omeprazole and gentamicin on the biochemical and histopathological alterations of the hypoxia/reoxygenation induced intestinal injury in newborn rats. Pediatr Surg Int 21:800–805PubMedCrossRefGoogle Scholar
  14. 14.
    Biswas K, Bandyopadhyay U, Chattopadhyay I (2003) A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical. J Biol Chem 278(13):10993–11001PubMedCrossRefGoogle Scholar
  15. 15.
    Suzuki M, Mori M, Miura S (1996) Omeprazole attenuates oxygen-derived free radical production from human neutrophils. Free Radic Biol Med 21:727–731PubMedCrossRefGoogle Scholar
  16. 16.
    Megison SM, Horton W, Chao H (1990) Prolonged survival and decreased mucosal injury after low dose enteral allopurinol prophylaxis in mesenteric ischemia. J Pediatr Surg 25:917–921PubMedCrossRefGoogle Scholar
  17. 17.
    Okhawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by TBA reaction. Anal Biochem 95:351–358CrossRefGoogle Scholar
  18. 18.
    Stoll BJ, Kanto WP, Glass RI (1980) Epidemiology of necrotizing enterocolitis: a case control study. J Pediatr 96(3):447–451PubMedCrossRefGoogle Scholar
  19. 19.
    Wiswell TE, Robertson CF, Jones TA (1988) Necrotizing enterocolitis in full-term infants. Am J Dis Child 142:532–535PubMedGoogle Scholar
  20. 20.
    Santulli TV, Shullinger JN, Heird WC (1975) Acute necrotizing enterocolitis in infancy: a review of 64 cases. Pediatrics 55:376–387PubMedGoogle Scholar
  21. 21.
    Kliegman RM, Walker WA, Yolken RH (1993) Necrotizing enterocolitis: research agenda for a disease of unknown etiology and pathogenesis. Pediatr Res 34:701–708PubMedCrossRefGoogle Scholar
  22. 22.
    Kosloske AM (1994) Epidemiology of necrotizing enterocolitis. Acta Paediatr Suppl 396:2–7PubMedCrossRefGoogle Scholar
  23. 23.
    Kosloske AM (1979) Necrotizing enterocolitis in the neonate. Surg Gynecol Obstet 148:259–269PubMedGoogle Scholar
  24. 24.
    Kliegman RM, Fanaroff AA (1984) Necrotizing enterocolitis. N Engl J Med 310(17):1093–1103PubMedGoogle Scholar
  25. 25.
    Barlow B, Santulli TV, Heird CW (1974) An experimental study of acute neonatal enterocolitis––the importance of breast milk. J Pediatr Surg 9(5):587–595PubMedCrossRefGoogle Scholar
  26. 26.
    Touloukian RJ, Posch JN, Spencer R (1972) The pathogenesis of ischemic gastroenterocolitis of the neonate. J Pediatr Surg 2:194CrossRefGoogle Scholar
  27. 27.
    Grisham MB, Hernandez LA, Granger DN (1986) Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol 251:567–574Google Scholar
  28. 28.
    Granger DN, Rutili G, McCord JM (1981) Superoxide radicals in feline intestinal ischemia. Gastroenterology 81(1):22–29PubMedGoogle Scholar
  29. 29.
    Hirata Y, Taguchi T, Nakao M (1996) The relationship between the adenine nucleotide metabolism and the conversion of the xanthine oxidase enzyme system in ischemia––reperusion of the rat small intestine. J Pediatr Surg 31:1199–1204PubMedCrossRefGoogle Scholar
  30. 30.
    Lubin B, Machlin LJ (1982) Vitamin E: biochemical, hematological and clinical aspects. Ann NY Acad Sci 393Google Scholar
  31. 31.
    Bertram GK (2001) Proton pump inhibitors basic and clinical pharmacology. Lange 8th edition 1067Google Scholar
  32. 32.
    Horn J (2000) The proton-pump inhibitors:similarities and differences. Clin Ther 22:266–280PubMedCrossRefGoogle Scholar
  33. 33.
    Wandall JH (1992) Effects of omeprazole on neutrophil chemotaxis superoxide production, degranulation and translocation of cytochrome b-245. Gut 33:617–621PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Faysal O. Cadir
    • 1
  • Unal Bicakci
    • 1
  • Burak Tander
    • 1
    Email author
  • Birsen Kilicoglu-Aydin
    • 1
  • Riza Rizalar
    • 1
  • Ender Ariturk
    • 1
  • Oguz Aydin
    • 1
  • Ferit Bernay
    • 1
  1. 1.Ondokuz Mayis UniversitySamsunTurkey

Personalised recommendations